UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027725
Receipt number R000031761
Scientific Title The safety of laparoscopic ICG fluorescence imaging surgery
Date of disclosure of the study information 2017/06/14
Last modified on 2020/12/14 11:08:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The safety of laparoscopic ICG fluorescence imaging surgery

Acronym

The safety of laparoscopic ICG fluorescence imaging surgery

Scientific Title

The safety of laparoscopic ICG fluorescence imaging surgery

Scientific Title:Acronym

The safety of laparoscopic ICG fluorescence imaging surgery

Region

Japan


Condition

Condition

All diseases suitable for gastroenterologic surgery.

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To analyze the safety of the ICG fluorescence imaging surgery in gastroenterologic surgery.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

The occurrence of the adverse effect of ICG

Key secondary outcomes

operative method, operative time, blood loss, postoperative comlication, others


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

The subject of this study is almost all laparoscopic surgeries. After the administration of ICG intraoperatively, the obsevation is performed under ICG fluorescence image-navigation using an image-enhanced laparoscopy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Suitable for surgery under general anesthesia.
2) Over 20 years old.
3) Having a potential demand for a detection of vessels, arteries, bile ducts, or lymphatics under the fatty layer.
4) The following operation:Thoracoscopic esophagectomy, Laparoscopic gastrectomy, Laparoscopy and endoscopy cooperative surgery, Laparoscopic enterectomy, Laparoscopic coloctomy, Laparoscopic proctectomy, Laparoscopic abdominoperineal resection, Laparoscopic colecystectomy, Laparoscopic common bile duct exploration, Laparoscopic hepatectomy, Laparoscopic derooting for liver cyst.

Key exclusion criteria

1) Having allergy for ICG.
2) Having allergy for iodic contrast medium.
3) Having allergy for various drugs.
4) Having psychological or neurological disease.
5) difficult to draw an informed consent.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Toshikatsu
Middle name
Last name Tsuji

Organization

Ishikawa prefectural central hospital

Division name

Department of Gastroenterological Surgery

Zip code

920-8530

Address

2-1, Kuratsukihigashi, Kanazawa, Ishiwaka 920-8530 Japan

TEL

+81-76-237-8211

Email

toshi_toshi25@yahoo.co.jp


Public contact

Name of contact person

1st name Toshikatsu
Middle name
Last name Tsuji

Organization

Ishikawa prefectural central hospital

Division name

Department of Gastroenterological Surgery

Zip code

920-8530

Address

2-1, Kuratsukihigashi, Kanazawa, Ishiwaka 920-8530 Japan

TEL

+81-76-237-8211

Homepage URL


Email

toshi_toshi25@yahoo.co.jp


Sponsor or person

Institute

Ishikawa prefectural central hospital

Institute

Department

Personal name



Funding Source

Organization

Ishikawa prefectural central hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ishikawa prefectural central hospital

Address

2-1, Kuratsukihigashi, Kanazawa, Ishiwaka 920-8530 Japan

Tel

+81-76-237-8211

Email

tmurai@ipch.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

石川県立中央病院(石川県)


Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 15 Day

Date of IRB

2017 Year 03 Month 30 Day

Anticipated trial start date

2017 Year 06 Month 14 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 06 Month 12 Day

Last modified on

2020 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031761


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name